<?xml version="1.0" encoding="UTF-8"?>
<p>Calcineurin and mammalian target of rapamycin inhibitors are not associated with major concerns of infections.
 <sup>
  <xref rid="CIT0082" ref-type="bibr">82</xref>
 </sup> Indeed, mammalian target of rapamycin inhibition has been associated with possible antiviral activity,
 <sup>
  <xref rid="CIT0083" ref-type="bibr">83</xref>
 </sup> and calcineurin inhibition was reported to suppress coronaviruses replication.
 <sup>
  <xref rid="CIT0084" ref-type="bibr">84</xref>
 </sup> Treatment withdrawal is not recommended; however, due to the possible interactions with some antiviral agents, a dose adjustment or suspension could be required in the case of SARS-CoV-2 patients beingtreated with specific drugs.
 <sup>
  <xref rid="CIT0027" ref-type="bibr">27</xref>
 </sup>
</p>
